Onyx (ONXX) volatility flat into Kyprolis FDA panel vote

Article Stock Quotes (1) Comments (0)

Onyx Pharmaceutical (Nasdaq: ONXX) overall option implied volatility of 50 is near its 26-week average of 53 according to Track Data, suggesting non-directional price movement as shares are halted into a FDA panel vote for Kyprolis.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Brean Capital Raises Onyx (ONXX) Price Target to $115
• Highway Holdings (HIHO) Halted Again on Circuit Breaker; Last Up 80%
• UPDATE: Chile regulators stopped build, imposed sanctions on Barrick Gold (ABX)

Create E-mail Alert Related Categories

Options

Related Entities

Options

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?